Results 191 to 200 of about 210,919 (300)

MUCL1 in triple-negative breast cancer: a novel marker associated with the luminal androgen receptor subtype. [PDF]

Breast Cancer Res
Klaus FL, Kitzke I, Klein E, Mogler C, Muckenhuber A.   +4 more
europepmc   +1 more source

Urologic Bacteriome: The Hero or the Villain in Prostate Cancer Onset, Progression, and Treatment?

Medicinal Research Reviews, EarlyView.
ABSTRACT Prostate cancer (PCa) is the second most frequently diagnosed cancer in men worldwide and the fifth leading cause of cancer‐related mortality, presenting urgent unmet clinical needs in diagnosis and treatment. The recognition of the microbiome as a key factor in human health has prompted numerous studies, revealing an exciting new approach to ...
Lara R. S. Fonseca, Mariana Feijó, Cátia V. Vaz, Bruno J. Pereira, Sandra Laurentino, Ana Palmeira‐de‐Oliveira, Sílvia Socorro   +6 more
wiley   +1 more source

The Role of Androgen Receptor and Antiandrogen Therapy in Breast Cancer: A Scoping Review. [PDF]

Curr Oncol
Ghidini A, Bukovec R, Roncari L, Garassino I, Cribiù FM, Petrelli F.   +5 more
europepmc   +1 more source

Outcomes of Direct Vocal Fold Testosterone Injections in Hormone‐Naïve Adults: A Case Series

Otolaryngology–Head and Neck Surgery, EarlyView.
Abstract Two nonbinary testosterone‐naïve individuals were seen at the Northwestern Memorial Hospital Voice Clinic. The objective was to determine the effectiveness of direct testosterone injections to the vocal folds for voice masculinization in testosterone‐naïve individuals.
Mariah E. Morton‐Jones, Zhe‐chen Guo, Jaymie Bromfield, Kristen Lee, Jonelyn Langenstein, Andrew P. Stein   +5 more
wiley   +1 more source

Androgen receptor signaling as a new target for intervention in acute myeloid leukemia. [PDF]

Blood Adv
Qian F, Sarkar D, Arner BE, Peduzzi VM, Bai Y, Ruan B, Jia B, Zheng H, Paulson RF, Prabhu KS.   +9 more
europepmc   +1 more source

Exploring the Reproductive Toxicity of Bisphenol S Through a Network Toxicology and Molecular Docking Analysis

Pediatric Discovery, EarlyView.
Utilizing network toxicology, molecular docking, and dynamic simulations to investigate the potential reproductive toxicity of bisphenol S (BPS). ABSTRACT The aim of this study was to investigate the potential reproductive toxicity of bisphenol S (BPS) and the related molecular mechanisms through a network toxicology approach.
Siyuan Wang, Yan Fu, Xu Huang, Qitong Guo, Xiangqin Zheng, Shengde Wu, Lianju Shen, Guanghui Wei   +7 more
wiley   +1 more source

Inhibition of nuclear import suppresses androgen receptor action and overcomes resistance in prostate cancer. [PDF]

BMC Cancer
Wang X, Xu X, Fang S, Shi X, Yang Y.
europepmc   +1 more source

Multiple eumenorrheic cycles are necessary to observe a significant increase in estrogen exposure and ovulation in exercising women with functional hypothalamic oligo/amenorrhea undergoing a nutritional intervention: Insights from the REFUEL study

PM&R, EarlyView.
Abstract Background Due to consequences of energy‐related oligo‐/amenorrhea (Oligo/Amen) among exercising females, recovery of menses (ROM) is a priority. ROM is inconsistently defined and rarely reported with reproductive hormone (estrogen, progesterone) data, making it difficult to know when females achieve adequate recovery. Objective The purpose of
Rebecca J. Mallinson, Nancy I. Williams, Emily A. Ricker, Heather C. M. Allaway, Mary Jane De Souza   +4 more
wiley   +1 more source

Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01. [PDF]

Future Oncol
Azad AA, Agarwal N, Armstrong AJ, Hellmis E, Sugimoto M, Ürün Y, Xing N, Aregay M, Lima J, Meulendijks D, Chi KN.   +10 more
europepmc   +1 more source

Molecular and genomic advances in breast cancer: A comprehensive review of predictive and therapeutic innovations

Precision Medical Sciences, EarlyView.
Breast cancer subtypes, estrogen receptor‐positive (ER+), HER2‐enriched, and TNBC, are defined by genomic and epigenetic signatures. Multi‐omics profiling, immunotherapy, liquid biopsy, and AI‐driven radiogenomics enable precision medicine. Tools like Oncotype DX and PAM50 support personalized care.
Samina Malik, Arif Malik, Shahzad Ahmad, Hassan Mohsin, Shazia Iqbal   +4 more
wiley   +1 more source